伴随性神经病理学和阿尔茨海默病的非典型表现
Stefanie D Pina-Escudero1,2, Renaud La Joie2, Salvatore Spina2
1Global Brain Health Institute University of California San Francisco California USA.
Alzheimer's & dementia (Amsterdam, Netherlands)
|July 23, 2024
概括
并发性神经病理学不能解释非典型的阿尔茨海默病 (AD) 呈现或更快的认知衰退. 阿吉罗菲尔粒细胞疾病与非典型的AD有关,但典型和非典型的AD群体之间的整体并发症病理是相似的.
科学领域:
- 神经病理学神经病理学
- 神经退行性疾病 神经退行性疾病
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 阿尔茨海默病 (AD) 呈现出典型的记忆障碍和非典型的非记忆障碍综合征.
- 伴随性神经病理在非典型AD表达中的作用尚未得到充分研究.
研究的目的:
- 调查非典型的AD是否与典型的AD相比表现出增加的并发性神经病理.
- 为了确定合并性神经病理是否有助于非典型阿尔茨海默病的加速临床衰退.
主要方法:
- 分析了来自60例非典型和101例典型AD病例的临床病理学数据.
- 群体间共患病态和认知衰退 (迷你精神状态检查 - MMSE) 的统计比较.
主要成果:
- 在典型的和非典型的AD之间,并发症病理的总数没有显著差异 (p=0.09).
- 阿吉罗菲尔粒细胞疾病与非典型的AD呈现有关 (p=0.008).
- 血管性脑损伤在典型的AD中更为普遍 (p=0.022),而非典型的AD显示出更的MMSE下降 (p=0.033).
结论:
- 并发性神经病理变化不太可能是非典型AD呈现的主要驱动因素.
- 异型阿尔茨海默病患者的加速认知衰退并不能由该队列中伴随性病理的较高负担解释.
更多相关视频
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.0K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Parkinson's Disease: Overview
512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
